| NCT Number | NCT07491289 |
| Lead Sponsor | Changchun GeneScience Pharmaceutical Co., Ltd. |
| Conditions | Hepatic Impairment and Healthy Female |
| Enrollment | 24 participants |
| Start Date | 2026-04-20 |
| Primary Completion | 2027-01-31 (estimated) |
| Study Completion | 2027-06-30 (estimated) |
| Updated on ClinicalTrials.gov | 2026-03-24 |